The GLP-1 Cost Problem — and How CoraDoc Solves It

GLP-1 receptor agonists have transformed metabolic health treatment. The clinical data is clear — the STEP 1 trial (NEJM, 2021) and SURMOUNT-5 trial (NEJM, 2025) established these medications as among the most impactful pharmacological interventions for obesity studied in modern medicine. But access has remained a significant barrier for most patients.

Brand-name GLP-1 medications often cost $800–$1,200 per month without insurance. Most insurance plans restrict or deny GLP-1 coverage for weight management. And many telehealth platforms that offer compounded GLP-1 medications have replicated the high-cost subscription model in a lower price tier — still charging $150–$399/month with auto-renewing billing.

CoraDoc™ was built around a different premise: a provider-supervised GLP-1 program should be priced as a one-time purchase, not a recurring subscription. Here is how that model works and why it keeps costs down.

The Structural Reasons CoraDoc Can Offer $99/Month

Telehealth Eliminates Physical Overhead

Traditional weight loss clinics carry significant fixed costs: office leases, administrative staff, waiting rooms, equipment, and in-person scheduling infrastructure. CoraDoc operates entirely via telehealth, eliminating these overhead layers. The savings are passed directly to patients through lower program pricing.

Direct Pharmacy Partnership

CoraDoc’s pharmacy partner, DIRX, ships compounded semaglutide and tirzepatide directly to patients. There is no retail pharmacy markup, no middleman pharmacy benefit manager, and no per-transaction fee added by an intermediary. The medication goes from the compounding pharmacy to your door.

All-Inclusive Pricing Structure

CoraDoc bundles the provider consultation, medication, 2-day shipping, and all supplies into a single price. Platforms that price these components separately — charging $50 for the consult, $20 for shipping, and $15 for supplies — effectively advertise a lower medication price while delivering the same or higher total cost. CoraDoc’s all-inclusive model makes the real price transparent from the start.

One-Time Payment — No Subscription Infrastructure

Subscription billing models require significant infrastructure to manage: retry logic for failed payments, cancellation handling, refund processing, and customer service to manage billing disputes. CoraDoc’s one-time payment model is operationally simpler — and the savings in billing infrastructure reduce overhead that would otherwise be passed to patients.

Complete Pricing — Every CoraDoc GLP-1 Program

All plans include the Triple Free Promise: free provider visit, free 2-day shipping via DIRX pharmacy, and free supplies. One charge. No auto-renew. No membership fee.

The Rise of GLP-1 Medications — Why Affordability Matters

GLP-1 receptor agonists work by mimicking the GLP-1 hormone your body naturally produces after eating. This hormone signals fullness to the brain, slows digestion, and helps regulate blood sugar. The clinical outcomes across multiple large-scale trials have been substantial.

The SURMOUNT-5 trial (NEJM, 2025) and STEP 1 trial (NEJM, 2021) established GLP-1 class medications as among the most impactful weight management interventions available. But clinical efficacy is irrelevant if the program costs more than patients can afford — or if subscription billing causes patients to drop off before completing a full course of therapy.

CoraDoc’s one-time payment model is designed to support treatment completion. When patients pay once for a defined program, there is no month-by-month financial decision point that might cause them to discontinue early.

Why LegitScript Certification Matters

CoraDoc™ holds LegitScript certification — the independent verification standard used by Google and Meta to identify legally compliant online healthcare providers. Achieving this certification requires passing a rigorous review of prescribing practices, pharmacy sourcing, physician oversight protocols, and legal compliance across all operating states.

In 2026, the FDA issued warning letters to multiple GLP-1 telehealth platforms for non-compliant practices. LegitScript certification distinguishes providers operating under ongoing third-party verified compliance standards from those that are not. This is a meaningful differentiator for patients choosing between platforms, not just a marketing badge.

CoraDoc vs. Major GLP-1 Subscription Platforms — 2026

Making GLP-1 Treatment Accessible Without Compromising Oversight

Affordable pricing should not mean reduced medical standards. Every CoraDoc™ program includes a licensed physician review of your individual health intake — not an automated algorithm, not a rubber-stamp approval, but a board-certified physician evaluating your specific medical profile before any prescription is issued.

If your physician determines that a GLP-1 program is not medically appropriate for you, you will be advised accordingly. CoraDoc does not issue blanket approvals. The physician group DoctorsNow and VSDHP oversee all prescribing through the CoraDoc™ platform.

Patients with questions can reach CoraDoc’s care team Monday–Friday at 855-983-5336 or careteam@coradoc.com. Your licensed provider remains accessible throughout your program.

Accepted Payment Methods

CoraDoc™ accepts: Visa, Mastercard, American Express, HSA/FSA cards, Afterpay (4 interest-free installments), Klarna, and Affirm financing. No subscription billing is set up — your card is charged once.